# Lutein Cognitive Performance Randomized Trial: What the Evidence Says
Canonical: https://www.migaku.app/guides/lutein-cognitive-performance-randomized-trial-evidence-review
Category: evidence-review
Summary: Lutein Cognitive Performance Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pa
Last reviewed: 2026-06-16
Reviewed by: Migaku Evidence Review
# Lutein Cognitive Performance Randomized Trial: What the Evidence Says

## Quick Answer

Lutein Cognitive Performance Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 randomized trial, 1 narrative review.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Effects of one avocado a day for six months on cognitive performance in overweight adults: A randomized controlled trial | randomized trial | 2 | 2026-06-01 | 10.1016/j.jnha.2026.100847 |
| The role of nutrition and multimodal lifestyle interventions in Alzheimer’s prevention and management: a mini-review | narrative review | 3 | 2026-04-08 | 10.3389/fnut.2026.1818913 |

## What The Sources Report

- Dietary patterns rich in antioxidants, unsaturated fats, and fiber have been associated with favorable effects on brain health and cognitive performance. [Lee Grace J. (2026); evidence level 2]
- Polyphenol-rich foods such as blueberries and cocoa have been shown to enhance cerebral blood flow and brain activation and are linked to improved cognitive performance and reduced cognitive decline in older adults. [Lee Grace J. (2026); evidence level 2]
- For instance, a three-year RCT evaluating the Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet showed its potential to slow cognitive decline and reduce brain atrophy in at-risk older adults, as assessed by a validated cognitive battery. [Zhang Hailong (2026); evidence level 3]
- Similarly, the two-year Finnish Geriatric Intervention Study (FINGER), a multidomain program encompassing diet, exercise, and cognitive training, was shown to improve global cognition in at-risk elderly, with enhanced benefits observed in carriers of the apolipoprotein E ε4 (APOE4) allele. [Zhang Hailong (2026); evidence level 3]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is trial evidence in the current set, but population and intervention details still matter. For lutein cognitive performance randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Lee Grace J. (2026). Effects of one avocado a day for six months on cognitive performance in overweight adults: A randomized controlled trial. DOI: 10.1016/j.jnha.2026.100847. PMCID: PMC13098412. PMID: 41999682. License: https://creativecommons.org/licenses/by-nc-nd/4.0/. https://pmc.ncbi.nlm.nih.gov/articles/PMC13098412/
- Zhang Hailong (2026). The role of nutrition and multimodal lifestyle interventions in Alzheimer’s prevention and management: a mini-review. DOI: 10.3389/fnut.2026.1818913. PMCID: PMC13099917. PMID: 42027570. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13099917/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.